Mechanism for acute oral desensitization to antibiotics

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 61, Issue 8, 2006, Pages 954-958

  Woo, H Y ^a   Kim, Y S ^a   Kang, N I ^a   Chung, W C ^a   Song, C H ^a   Choi, I W ^b   Choi, I H ^b   Lee, H K ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

Anaphylaxis; Mast cell; Oral desensitization; Penicillin V

Indexed keywords

ANTIBIOTIC AGENT; HAPTEN; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; PENICILLIN V; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DRUG HYPERSENSITIVITY; HISTAMINE BLOOD LEVEL; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ANAPHYLAXIS;

ADMINISTRATION, ORAL; ANAPHYLAXIS; ANIMALS; ANTI-BACTERIAL AGENTS; DESENSITIZATION, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; DRUG HYPERSENSITIVITY; FEMALE; HISTAMINE; IMMUNOGLOBULIN E; MAST CELLS; MICE; PENICILLIN V; PLATELET ACTIVATING FACTOR;

EID: 33745766082     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01147.x     Document Type: Article

References (28)

1. Reisman RE, Rose NR, Witebsky E, Arbesman CE. Penicillin allergy and desensitization. J Allergy 1962;33: 178-187.
2. Sullivan TJ. Antigen-specific desensitization of patients allergic to penicillin. J Allergy Clin Immunol 1982;69: 500-508.
3. Sullivan TJ, Yecies LD, Shatz GS, Parker CW, Wedner HJ. Desensitization of patients allergic to penicillin using orally administered beta-lactam antibiotics. J Allergy Clin Immunol 1982;69:275-282.
4. Wendel Jr GD, Stark BJ, Jamson RB, Molina RD, Sullivan TJ. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 1985;312:1229-1232.
5. Borish L, Tamir R, Rosenwasser LJ. Intravenous desensitization to beta-lactam antibiotics. J Allergy Clin Immunol 1987;80:314-319.
6. Papakonstantinou G, Bogner JR, Hofmeister F, Hehlmann R. Cefotaxime desensitization. Clin Investig 1993;71:165-167.
7. Matz J, Borish LC, Routes JM, Rosenwasser LJ. Oral desensitization to rifampin and ethambutol in mycobacterial disease. Am J Respir Crit Care Med 1994;149:815-817.
8. Rosa ML, Romeo MA, Di Felicia F, Russo G. Desensitization treatment for anaphylactoid reactions to desferrioxamine in a pediatic patient with thalassemia. J Allergy Clin Immunol 1996;97:127-128.
9. Battersby NC, Patel L, David TJ. Increasing dose regimen in children with reactions to ceftazidime. Clin Exp Allergy 1995;25:1211-1217.
10. Essayan DM, Kagey-Sobotka A, Colarusso PJ, Lichtenstein LM, Ozols RF, King ED. Successful parenteral desensitization to paclitaxel. J Allergy Clin Immunol 1996;97:42-46.
11. Villavicencio AT, Hey LA, Patel D, Bressler P. Acute cardiac and pulmonary arrest after infusion of vancomycin with subsequent desensitization. J Allergy Clin Immunol 1997;100:853-854.
12. Chisholm CA, Katz VL, McDonald TL, Bowes WA Jr. Penicillin desensitization in the treatment of syphilis during pregnancy. Am J Perinatol 1997;14:553-554.
13. Levine BB, Redmond AP, Voss HE, Zolov DM. Prediction of penicillin allergy by immunological tests. Ann N Y Acad Sci 1967;145:298-309.
14. Pedersen-Bjergarrd J. Specific hyposensitization of patients with penicillin allergy. Acta Allergol 1969;24:333-361.
15. Parker CW. Practical aspects of diagnosis and treatment of patients who are hypersensitive to drugs. In: Samter M, editor. Hypersensitivity to drugs. New York: Pergamon Press, 1972:367.
16. Park JS, Choi IH, Lee DG, Han SS, Ha TY, Lee JH et al. Anti-IL-4 monoclonal antibody prevents antibiotics-induced active fatal anaphylaxis. J Immunol 1997;158:5002-5006.
17. Choi IH, Shin YM, Park JS, Lee MS, Han EH, Chai OH et al. Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice. J Exp Med 1998;188:1587-1592.
18. Fleming TJ, Donnadieu E, Song CH, Laethem FV, Galli SJ, Kinet JP. Negative regulation of FcεRI-mediated degranulation by CD81. J Exp Med 1997;186:1307-1314.
19. Braquet P, Etienne A, Touvay C, Bourgain RH, Lefort J, Vargaftig BB. Involvement of platelet-activating factor in respiratory anaphylaxis, demonstrated by PAF-acether inhibitor BN 52021. Lancet 1985;1:1501.
20. Vilain B, Lagente V, Touvay C, Desquand S, Rendon J, Lefort J et al. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021. Phamacol Res Commun (Suppl.) 1986;18:119-126.
21. de Weck AL, Girard JP. Specific inhibition of allergic reactions to penicillin in man by a monovalent hapten. II. Clinical studies. Int Arch Allergy 1972;42:798-815.
22. Steinman RM, Mellman IS, Muller MA, Cohen ZA. Endocytosis and recycling of plasma membrane. J Cell Biol 1983;96:1-27.
23. Fewtrell C, Metzger H. Larger oligomers of IgE are more effective than dimers in stimulating rat basophilic cells. J Immunol 1980;125:701-710.
24. Furuichi K, Rivera J, Isersky C. The fate of IgE bound to rat basophilic leukemia cells. III. Relationships between antigen-induced endocytosis and serotonin release. J Immunol 1984;133:1513-1520.
25. Metzger H, Alcaraz G, Hohman R, Kinet JP, Pribluda V, Quarto R. The receptor with high affinity for immunoglobulin E. Ann Rev Immunol 1986;4:419-470.
26. Furuichi K, Rivera J, Buonocore LM, Isersky C. Recycling of receptor-bound IgE by rat basophilic leukemia cells. J Immunol 1986;136:1015-1022.
27. de Andres B, Rakasz E, Hagen M, McCormik ML, Mueller AL, Elliot D et al. Lack of Fc-epsilon receptors on murine eosinophils: implication for the functional significance of elevated IgE and eosinophils in parasitic infections. Blood 1997;89:3826-3836.
28. Capron M, Morita M, Woerly G, Lengrand F, Gounni AS, Delaporte E et al. Differentiation of eosinophils from cord blood cell precursors: kinetics of FcεRI and FcεRII expression. Int Arch Allergy Immunol 1997;113:48-50.